arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

SkyAI, Inc.

SKYA
$1.20 ▲ +0.05 (+4.35%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
22 Visible periods
24 Metrics
Peer-ranked Benchmarks
Price Chart
42
Health
Weak
Moderately Bearish
auto_awesome

Analytical Summary

SkyAI, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $87.1M
Dividend Yield
Revenue Growth
Op. Margin
ROIC -38.1%
FCF / Share $-0.04
Trailing P/E
Price / Book 0.3x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

22-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$192.78K
↑ +288.6%
Net Income Profit after all expenses
$-86.24M
↑ +52.8%
FCF / Share Free cash flow per share
$-0.04
↑ +89.8%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
8
Financial Health
93
Cash Quality
23

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 22 quarters